130 related articles for article (PubMed ID: 18381245)
1. Diabetic osteopathy and the IGF system in the Goto-Kakizaki rat.
Ahmad T; Ugarph-Morawski A; Lewitt MS; Li J; Sääf M; Brismar K
Growth Horm IGF Res; 2008 Oct; 18(5):404-411. PubMed ID: 18381245
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
3. Peripheral quantitative computed tomography for the detection of diabetic osteopathy: a study in the Goto-Kakizaki rat.
Ahmad T; Ohlsson C; Ostenson CG; Kreicbergs A
Invest Radiol; 2003 Mar; 38(3):171-6. PubMed ID: 12595798
[TBL] [Abstract][Full Text] [Related]
4. Skeletal changes in type-2 diabetic Goto-Kakizaki rats.
Ahmad T; Ohlsson C; Sääf M; Ostenson CG; Kreicbergs A
J Endocrinol; 2003 Jul; 178(1):111-6. PubMed ID: 12844342
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus a risk for osteoporosis?
Leidig-Bruckner G; Ziegler R
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
[TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
[TBL] [Abstract][Full Text] [Related]
9. [Diabetic osteopathy].
Ilić J; Kovacev B
Med Pregl; 2005; 58(3-4):147-52. PubMed ID: 16526212
[TBL] [Abstract][Full Text] [Related]
10. Corticosterone regulation of insulin-like growth factor I, IGF-binding proteins, and growth in streptozotocin-induced diabetic rats.
Rodgers BD; Strack AM; Dallman MF; Hwa L; Nicoll CS
Diabetes; 1995 Dec; 44(12):1420-5. PubMed ID: 7589849
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
[TBL] [Abstract][Full Text] [Related]
12. Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats.
Bourrin S; Ammann P; Bonjour JP; Rizzoli R
Endocrinology; 2000 Sep; 141(9):3149-55. PubMed ID: 10965885
[TBL] [Abstract][Full Text] [Related]
13. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
14. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
Bauss F; Lang K; Dony C; Kling L
Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
[TBL] [Abstract][Full Text] [Related]
15. Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy.
Bach LA; Dean R; Youssef S; Cooper ME
Nephrol Dial Transplant; 2000 Mar; 15(3):347-54. PubMed ID: 10692520
[TBL] [Abstract][Full Text] [Related]
16. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes.
Landau D; Chin E; Bondy C; Domene H; Roberts CT; Gronbaek H; Flyvbjerg A; LeRoith D
Endocrinology; 1995 May; 136(5):1835-42. PubMed ID: 7536658
[TBL] [Abstract][Full Text] [Related]
17. Specific alterations of the insulin-like growth factor I system in the cerebellum of diabetic rats.
Busiguina S; Chowen JA; Argente J; Torres-Aleman I
Endocrinology; 1996 Nov; 137(11):4980-7. PubMed ID: 8895371
[TBL] [Abstract][Full Text] [Related]
18. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
[TBL] [Abstract][Full Text] [Related]
19. Protein glycation: its role in the changes induced by diabetes in the properties of the serum insulin-like growth factor-I binding proteins.
Cortizo AM; Gagliardino JJ
J Endocrinol; 1991 Oct; 131(1):33-8. PubMed ID: 1720805
[TBL] [Abstract][Full Text] [Related]
20. Relationships of serum levels of insulinlike growth factors with indices of bone metabolism and nutritional conditions in hemodialysis patients.
Nanba K; Nagake Y; Miyatake N; Nakao K; Akagi S; Sugimoto T; Yamasaki H; Oishi K; Ichikawa H; Makino H
Nephron; 2001 Oct; 89(2):145-52. PubMed ID: 11549896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
